60. 再生不良性貧血 Aplastic anemia Clinical trials / Disease details

臨床試験数 : 235 / 薬物数 : 381 - (DrugBank : 83) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 160

18 trials found

diseases per page:

Showing 1 to 10 of 18 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04099966 (ClinicalTrials.gov)	April 1, 2020	18/9/2019	AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B ...	Allogeneic Stem Cell Transplantation for Malignant and Non-malignant Hematologic Diseases Utilizing ...	Acute Leukemia;Severe Aplastic Anemia;Non-hodgkin Lymphoma;Hodgkin Lymphoma;Kostmann;Diamond Blackfa ...	Drug: alpha beta depletion	Mitchell Cairo	NULL	Not yet recruiting	N/A	30 Years	All	20	Phase 2	United States
2	NCT03836690 (ClinicalTrials.gov)	October 21, 2019	10/1/2019	Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation	Phase I Study of Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplant ...	Lymphoma;Leukemia;Myeloma;Myelodysplastic Syndromes;Severe Aplastic Anemia;Primary Immune Deficiency ...	Biological: CD62L- Tem	University College, London	Medical Research Council	Recruiting	16 Years	70 Years	All	18	Phase 1	United Kingdom
3	NCT03333486 (ClinicalTrials.gov)	December 7, 2017	2/11/2017	Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in T ...	A Phase II Trial of Haploidentical Allogeneic Stem Cell Transplantation Utilizing Mobilized Peripher ...	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Acute Leukemia in Remission;Acute ...	Drug: Cyclophosphamide;Drug: Fludarabine Phosphate;Other: Laboratory Biomarker Analysis;Procedure: Pe ...	Roswell Park Cancer Institute	NULL	Recruiting	1 Year	75 Years	All	58	Phase 2	United States
4	EUCTR2016-001223-31-GB (EUCTR)	11/10/2016	07/09/2016	Incidence of Invasive Fungal Disease in Patients receiving Immunosuppressive Therapy, Intensive Chem ...	Incidence of Invasive Fungal Disease in Patients receiving Immunosuppressive Therapy, Intensive Chem ...	Aplastic Anaemia, Myelodysplastic syndromes, Acute Myeloid Leukaemia undergoing immunosuppression th ...	Trade Name: Noxafil ® Product Name: Noxafil Gastro resistant tablets	King's College Hospital NHS Foundation Trust	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 4	United Kingdom
5	NCT02007811 (ClinicalTrials.gov)	November 2013	21/11/2013	Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrat ...	Prospective, Open-label, Multicentre Clinical Trial, Phase I/IIa, to Investigate the Safety and Tole ...	Acute Myeloid Leukemia;Acute Lymphoblastic Leukemia;Chronic Myeloid Leukemia;Non Hodgkin's Lymphoma; ...	Biological: allogeneic donor derived B-lymphocytes	University of Erlangen-Nürnberg Medical School	University Hospital Regensburg;Wuerzburg University Hospital;University Hospital, Essen;German Resea ...	Recruiting	18 Years	75 Years	Both	15	Phase 1/Phase 2	Germany
6	NCT01966367 (ClinicalTrials.gov)	March 2013	17/10/2013	CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantatio ...	CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated ...	Bone Marrow Failure Syndrome;Severe Aplastic Anemia;Severe Congenital Neutropenia;Amegakaryocytic Th ...	Biological: CD34 Stem Cell Selection Therapy	Diane George	NULL	Active, not recruiting	N/A	40 Years	All	37	Phase 1/Phase 2	United States
7	NCT01529827 (ClinicalTrials.gov)	February 28, 2012	6/2/2012	Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral B ...	A Phase II Trial of Reduced Intensity Allogeneic Stem Cell Transplantation With Fludarabine, Melphal ...	Accelerated Phase Chronic Myelogenous Leukemia;Adult Acute Lymphoblastic Leukemia in Remission;Adult ...	Drug: fludarabine phosphate;Drug: melphalan;Radiation: total-body irradiation;Drug: tacrolimus;Drug: ...	Roswell Park Cancer Institute	NULL	Completed	3 Years	75 Years	All	94	Phase 2	United States
8	NCT01500161 (ClinicalTrials.gov)	November 2011	18/11/2011	Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic ...	A Phase II Study Of Pooled Unrelated Donor Umbilical Cord Blood (UCB) Transplant For Patients With H ...	Acute Myelogenous Leukemia;Acute Lymphocytic Leukemia;Chronic Lymphocytic Leukemia;Chronic Myelogeno ...	Drug: Busulfan;Drug: Clofarabine;Drug: Fludarabine;Drug: Melphalan;Drug: Carmustine;Drug: Etoposide; ...	Texas Oncology Cancer Center	NULL	Terminated	18 Years	65 Years	Both	1	Phase 2	United States
9	NCT01129323 (ClinicalTrials.gov)	November 2009	21/4/2010	Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Seve ...	Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Seve ...	Severe Aplastic Anemia	Drug: Cyclophosphamide , Fludarabine, Rabbit ATG	City of Hope Medical Center	NULL	Withdrawn	N/A	21 Years	Both	0	N/A	United States
10	NCT00856388 (ClinicalTrials.gov)	January 14, 2009	4/3/2009	Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Pat ...	A Pilot Trial Of Reduced Intensity Allogeneic Stem Cell Transplantation With Fludarabine, Melphalan, ...	Accelerated Phase Chronic Myelogenous Leukemia;Acute Myeloid Leukemia With Multilineage Dysplasia Fo ...	Drug: fludarabine phosphate;Drug: melphalan;Radiation: total-body irradiation;Procedure: allogeneic h ...	Roswell Park Cancer Institute	National Cancer Institute (NCI)	Completed	3 Years	75 Years	All	62	N/A	United States

First Previous1 2Next Last